Recent News and Updates
Ultragenyx letter to the WD community
Read more: WDA Community Update from Ultragenyx Oct 2024 (PDF)
Gene therapy updates from the WDA
Read more: GTx-Updates (PDF)
WDA designates newest Wilson Disease Center of Excellence at University of California, Davis
Read more: https://health.ucdavis.edu/news/headlines/uc-davis-health-designated-wilson-disease-center-of-excellence/2024/09
Ultragenyx Wilson Disease Update April 2024
As Ultragenyx continues to advance its research for Wilson disease, please find a status update on the CYPRUS2+ study.The CYPRUS2+ study is designed with three stages. We are currently in Stage 1 where we are [...]
One Step Closer to a Newborn Screening Test for Wilson Disease
Key Proteo Submits De Novo Application to FDA for its First Newborn Screening Kit Potential to be the first IVD for the screening of Wilson Disease, Wiskott-Aldrich Syndrome, X-linked Agammaglobulinemia and Adenosine Deaminase Deficiency [...]
Ultragenyx Wilson Disease Gene Therapy Trial Update for WDA
As requested, we are providing an update on Stage 1 of our Cyprus2+ study, assessing safety and efficacy of UX701, an investigational gene therapy for the treatment of Wilson disease.The status update below is based [...]


